Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join Olink users, consortia, events and webinars to share insights and accelerate biomarker discovery.
Comprehensive statistical analysis & data visualization tools
Over 4,000 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Physiological Reports, 2022Quantifying the inflammatory secretome of human intermuscular adipose tissue
Kahn D., Macias E., Zarini S. et al.
Olink Target 96
Scientific Reports, 2022Association of extracellular vesicle inflammatory proteins and mortality
Noren Hooten N., Torres S., Mode N. et al.
Journal of Clinical Immunology, 2022SOCS1 Haploinsufficiency Presenting as Severe Enthesitis, Bone Marrow Hypocellularity, and Refractory Thrombocytopenia in a Pediatric Patient with Subsequent Response to JAK Inhibition
Michniacki T., Walkovich K., DeMeyer L. et al.
Olink Target 48
American Journal of Respiratory Cell and Molecular Biology, 2022Multiomic Signatures of Chronic Beryllium Disease Bronchoalveolar Lavage Cells Relate to T-Cell Function and Innate Immunity
Li L., Konigsberg I., Bhargava M. et al.
International Journal of Molecular Sciences, 2022Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker Discovery
Beltrami A., De Martino M., Dalla E. et al.
Nature Communications, 2022ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19
Pietzner M., Chua R., Wheeler E. et al.
Nordic Journal of Psychiatry, 2022Intercorrelation of physiological seizure parameters and hormonal changes in electroconvulsive therapy
Thörnblom E., Gingnell M., Cunningham J. et al.
Multiple Sclerosis and Related Disorders, 2022High-intensity resistance training in people with multiple sclerosis experiencing fatigue: A randomised controlled trial
Englund S., Piehl F., Kierkegaard M.
Journal of Molecular and Cellular Cardiology Plus, 2022Serial measurements of protein and microRNA biomarkers to specify myocardial infarction subtypes
Schulte C., Singh B., Theofilatos K. et al.
Nature Cardiovascular Research, 2022Identification of LTBP-2 as a plasma biomarker for right ventricular dysfunction in human pulmonary arterial hypertension
Boucherat O., Yokokawa T., Krishna V. et al.
Olink Explore 3072/384
Scientific Reports, 2022A disturbed balance between blood complement protective factors (FH, ApoE) and common pathway effectors (C5a, TCC) in acute COVID-19 and during convalesce
Laudanski K., Okeke T., Siddiq K. et al.
American Heart Journal Plus: Cardiology Research and Practice, 2022Higher plasma IL-6 and PTX3 are associated with worse survival in left heart failure with pulmonary hypertension
Helleberg S., Engel A., Ahmed S. et al.
Fluids and Barriers of the CNS, 2022Posthemorrhagic hydrocephalus associates with elevated inflammation and CSF hypersecretion via activation of choroidal transporters
Lolansen S., Rostgaard N., Barbuskaite D. et al.
International Journal of Obesity, 2022Heart failure in obesity: insights from proteomics in patients treated with or without weight-loss surgery
Karason K., Girerd N., Andersson-Asssarsson J. et al.
PROTEOMICS – Clinical Applications, 2022Plasma biomarkers for systemic inflammation in COVID‐19 survivors
Zhao J., Schank M., Wang L. et al.
Journal of Investigative Dermatology, 2022Comparison of the Inflammatory Circuits in Psoriasis Vulgaris, Non‒Pustular Palmoplantar Psoriasis, and Palmoplantar Pustular Psoriasis
Wang C., Haxhinasto S., Garcet S. et al.
Rheumatology, 2022Plasma proteomics identifies CRTAC1 as a biomarker for osteoarthritis severity and progression
Szilagyi I., Vallerga C., Boer C. et al.
Diabetologia, 2022Plasma prostasin: a novel risk marker for incidence of diabetes and cancer mortality
Bao X., Xu B., Muhammad I. et al.
Laboratory Investigation, 2022High-throughput proteomics: a methodological mini-review
Cui M., Cheng C., Zhang L.
Biomedicines, 2022A Targeted Proteomics Approach for Screening Serum Biomarkers Observed in the Early Stage of Type I Endometrial Cancer
Ura B., Capaci V., Aloisio M. et al.
4488 publications
Items per page
3501-3520 of 4488 publications